NCT07207941
Effect of Probiotics on Quality of Life, Activities of Daily Living and Anxiety in Post Stroke Patients
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved at least 2 years 3 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Sep 30, 2025 to Dec 31, 2027 Show 7 more changesShow less
- Recruitment opened
- Start date changed from estimate of Sep 30, 2025 to Jan 1, 2026
- Eligibility criteria expanded, about 9 words
- Study sites: 1 to 2
- Secondary endpoints: details revised at 3 of 3 entries
- Collaborator revised
- Study description expanded, about 2 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Primary Objective
Timeframe: 3 months
Secondary (3)
Secondary objectives: Activities of daily living
Secondary objective: Anxiety Score
Secondary objective: modified Rankin scale
Arms and interventions
InterventionActive comparator
Intervention group HEXBIO MCP Granule probiotics (Lactobacillus acidophilus, L. casei, L. lactis, Bifidobacterium bifidum, B. infantis, B. longum), one sachet twice daily for 3 months.
PlaceboPlacebo comparator
Placebo Control Matching placebo sachets, identical in appearance and schedule.
Dietary supplements: Hexbio
Other: Placebo
Sites
2 sites in 1 country